Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.41 |
| ▸ | BCHE | P06276 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | ABCB1 | P08183 | 10/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | BACE1 | P56817 | 2/20 | 0.36 |
| ▸ | F10 | P00742 | 1/20 | 0.36 |
| ▸ | SLC43A1 | O75387 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7902263 | 0.83 | L3MBTL1 (0.41) | BCHEALDH1A1ABCB1GAATSHR | |
| SCHEMBL14440540 | 0.83 | ALDH1A1 (0.43) | BCHEALDH1A1ABCB1GAATSHR | |
| SCHEMBL14440928 | 0.83 | ALDH1A1 (0.43) | BCHEALDH1A1ABCB1GAATSHR | |
| SCHEMBL14568965 | 0.83 | ALDH1A1 (0.43) | BCHEALDH1A1ABCB1GAATSHR | |
| SCHEMBL14428933 | 0.83 | ALDH1A1 (0.43) | BCHEALDH1A1ABCB1GAATSHR | |
| SCHEMBL16378350 | 0.82 | ALDH1A1 (0.37) | PTGES2BCHEALDH1A1ABCB1GAA | |
| SCHEMBL7150011 | 0.80 | ALDH1A1 (0.46) | PTGES2BCHEALDH1A1ABCB1GAA | |
| SCHEMBL7932128 | 0.78 | ALDH1A1 (0.38) | BCHEALDH1A1ABCB1GAATSHR | |
| SCHEMBL7691337 | 0.78 | ALDH1A1 (0.55) | ALDH1A1ABCB1GAATSHR | |
| SCHEMBL10148625 | 0.78 | NT5E (0.39) | BCHEALDH1A1ABCB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160144016-A1 | SYNTHETIC OLIGOSACCHARIDES FOR P. AERUGINOSA VACCINE | SYNGLYCO PHARMACEUTICALS, INC. (US) | 2016-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160144016-A1 | SYNTHETIC OLIGOSACCHARIDES FOR P. AERUGINOSA VACCINE | DDOST, FUT5, FUT6 | PTGES2 1076/4885BCHE 2286/4885ALDH1A1 4427/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.